Opioid Use Disorder Care during COVID-19 Disruptions
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:2 publications
Grant number: 173111
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$152,851.59Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Patrick McLaneResearch Location
CanadaLead Research Institution
University of AlbertaResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
Digital Health
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Minority communities unspecified
Occupations of Interest
Unspecified
Abstract
COVID-19 is disrupting opioid use disorder treatment, and the impacts of these disruptions are unknown. Community addictions clinics have switched to virtual care, decreased their opening hours, or closed. At the same time, opioid overdoses in Alberta and British Columbia have increased. It is currently not known whether patients are being supported through adjusted opioid use disorder care, or whether they are going undertreated. This project will combine review of opioid addiction clinic and emergency department data to profile the impact of COVID-19 on opioid use disorder treatment. Crucially, we will assess impacts of changes in opioid use disorder treatment for First Nations members, in partnership with the Blackfoot Confederacy.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC